RESUMO
Abnormal long noncoding RNA (lncRNA) expression plays an important role in tumor invasion and metastasis. Here, we show that lncRNA LY6E divergent transcript (LY6E-DT) levels are increased in breast cancer (BC) tissues. Transcription factor SP3 binds directly to the LY6E-DT promoter, activating its transcription. Moreover, LY6E-DT N6-methyladenosine modification by methyltransferase-like protein 14 (METTL14) promotes its expression, dependent on the "reader" insulin-like growth factor 2 mRNA binding protein 1(IGF2BP1)-dependent pathway. Notably, we discovered that the lncRNA LY6E-DT encodes a conserved 153-aa protein, "Metastatic-Related Protein" (MRP). Both LY6E-DT and MRP promote BC invasion and metastasis, and MRP expression could distinguish BC patients with lymph node metastasis from those without. Mechanistically, MRP binds heterogeneous nuclear ribonucleoproteins C1/C2 (HNRNPC), enhancing the interaction between HNRNPC and epidermal growth factor receptor (EGFR) mRNA, increasing EGFR mRNA stability and protein expression and subsequently activating the phosphatidylinositol 3kinase/protein kinase B signaling (PI3K) pathway. LncRNA LY6E-DT promotes the interaction between Y box binding protein 1 (YBX1) and importin α1 and increases YBX1 protein entry into the nucleus, where it transcriptionally activates zinc finger E-box-binding homeobox 1(ZEB1). Our findings uncover a novel regulatory mechanism underlying BC invasion orchestrated by LY6E-DT and its encoded MRP.
Assuntos
Neoplasias da Mama , RNA Longo não Codificante , Humanos , Feminino , Neoplasias da Mama/patologia , RNA Longo não Codificante/genética , RNA Longo não Codificante/metabolismo , Fosfatidilinositol 3-Quinases/metabolismo , Homeobox 1 de Ligação a E-box em Dedo de Zinco/genética , Receptores ErbB/genética , Receptores ErbB/metabolismo , RNA Mensageiro , Linhagem Celular Tumoral , Regulação Neoplásica da Expressão Gênica , Proliferação de Células/genética , Antígenos de Superfície , Proteínas Ligadas por GPI/genéticaRESUMO
In this work, a microfluidic chlorine gas sensor based on gas-liquid interface absorption and chemiluminescence detection was described. The liquid chemiluminescence reagent-alkaline luminol solution can be stably sandwiched between two convex halves of a microchannel by surface tension. When chlorine gas was introduced into the micro device, it was dissolved into the interfacial luminol solution and transferred to ClO(-), and simultaneously luminol was excited and chemiluminescence emitted. The emitted chemiluminescence light was perpendicularly detected by a photomultiplier tube on a certain detection region. The remarkable advantage of the detection system is that both adsorption and detection were carried out at the gas-liquid interface, which avoids the appearance of bubbles. The whole analytical cycle including filling CL reagent, sample injection, CL detection and emptying the device was as short as 30 s. The linear concentration range of chlorine gas detection with direct introduction of sample method is from 0.5 to 478 ppm. The detection limit of this method is 0.2 ppm for standard chlorine gas and the relative standard deviation of five determinations of 3.19 ppm spiked chlorine sample was 5.2%.